FDA NDC Directory · JSON-LD · Markdown

Risperidone

NDC 69339-181 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerNatco Pharma USA LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA091537
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRISPERIDONE (.25 mg/1)
Marketing started20231014
Package count1

External sources

Source: openFDA. Public-domain (CC0).